大麻素及其潜在的基于证据的精神病学益处 - - 批判性审查
Inga Dammann1,2, Cathrin Rohleder1,2,3, F Markus Leweke1,3
1Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Pharmacopsychiatry
|January 24, 2024
概括
大麻二醇 (CBD) 显示出治疗精神疾病的潜力,如精神分裂症,物质使用障碍和PTSD. 需要进一步的研究来确认其长期使用的疗效和安全性.
科学领域:
- 精神病学是一个精神病学.
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 内分泌大麻素系统是精神病治疗的有希望的目标.
- 大麻 (CBD) 在精神疾病中具有有利的安全性和多样化的效果.
- 现有的CBD在精神病学中的随机临床试验证据有限.
研究的目的:
- 进行关于CBD在精神疾病中的影响的临床研究的综合文献综述.
- 为了确定CBD已被调查的精神疾病.
- 评估目前关于CBD在精神病学中的有效性和安全性的证据.
主要方法:
- 在精神疾病中对CBD进行临床研究的全面文献搜索.
- 包括在2023年7月27日之前发表的案例研究,观察研究和RCT.
- 排除涉及纳比西摩尔或含有THC的大麻提取物的研究.
主要成果:
- 包括54篇出版物,涵盖了CBD对健康受试者和精神分裂症,SUD,焦虑症,PTSD和自闭症谱系障碍等疾病的影响.
- 没有发现有关酒精使用障碍,边缘性人格障碍,抑郁症,痴呆症或多动症的研究.
- CBD可能会改善精神分裂症,SUD和PTSD.
结论:
- 对于特定的精神疾病,CBD显示出治疗潜力.
- 需要进行更多受控的中长期临床试验,以确定CBD的疗效和安全性.
- 进一步研究CBD对神经活动和内分泌系统的影响是有必要的.
相关概念视频
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
195
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
195
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
278
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
278
Diagnostic and Statistical Manual of Mental Disorders (DSM)
56
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
56
Mania and Antimanic Drugs: Overview
181
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
181
Hallucinogens and Psychedelics
166
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
166
Anxiolytic Drugs: Benzodiazepines and Buspirone
766
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
766


